Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000903423-18-000545
Filing Date
2018-10-10
Accepted
2018-10-10 19:51:46
Documents
1
Period of Report
2018-10-10

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT sisitisky.html 3  
1 OWNERSHIP DOCUMENT sisitisky.xml 3 3569
  Complete submission text file 0000903423-18-000545.txt   4947
Mailing Address TPG CAPITAL 345 CALIFORNIA STREET, SUITE 3800 SAN FRANCISCO CA 94104
Business Address
Sisitsky Todd Benjamin (Reporting) CIK: 0001407884 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38693 | Film No.: 181117119

Mailing Address 210 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 210 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080 (650) 457-2700
Allogene Therapeutics, Inc. (Issuer) CIK: 0001737287 (see all company filings)

EIN.: 823562771 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)